StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
147
This month
10
This year
21
Publishing Date
2024 - 04 - 09
3
2024 - 04 - 03
2
2024 - 03 - 11
2
2023 - 12 - 11
4
2023 - 11 - 01
3
2023 - 10 - 25
2
2023 - 08 - 23
10
2023 - 03 - 20
2
2022 - 08 - 31
1
2022 - 07 - 08
1
2022 - 07 - 07
2
2022 - 06 - 30
1
2022 - 06 - 10
1
2022 - 06 - 03
1
2022 - 05 - 26
1
2022 - 04 - 07
1
2022 - 03 - 29
1
2022 - 03 - 09
1
2022 - 03 - 08
1
2022 - 02 - 10
1
2021 - 12 - 12
1
2021 - 11 - 15
5
2021 - 11 - 12
2
2021 - 10 - 27
1
2021 - 10 - 26
1
2021 - 10 - 22
1
2021 - 10 - 21
1
2021 - 10 - 14
1
2021 - 09 - 30
1
2021 - 07 - 13
1
2021 - 06 - 04
4
2021 - 06 - 01
1
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 21
2
2021 - 05 - 19
1
2021 - 05 - 18
2
2021 - 05 - 13
1
2021 - 05 - 12
1
2021 - 05 - 11
2
2021 - 04 - 29
2
2021 - 04 - 27
1
2021 - 04 - 20
2
2021 - 04 - 16
2
2021 - 04 - 13
1
2021 - 04 - 12
2
2021 - 04 - 09
1
2021 - 04 - 07
1
2021 - 04 - 02
4
2021 - 03 - 31
1
2021 - 03 - 25
1
2021 - 03 - 16
1
2021 - 03 - 10
1
2021 - 03 - 09
1
2021 - 03 - 05
1
2021 - 03 - 02
1
2021 - 02 - 16
1
2021 - 01 - 07
2
2021 - 01 - 05
1
2020 - 12 - 07
1
Sector
Consumer durables
1
Finance
1
Health technology
147
Producer manufacturing
2
Tags
Acquired
1
Advanced
1
Alliances
1
America
1
Announces collaboration
1
Annual needham
1
Annual needham virtual healthcare conference
1
Application
1
Association
3
Biotech-bay
15
Calendar of events
1
Cancer
14
Cell
3
Ces
1
Clearance
3
Cleared
1
Clinical-trials-phase-i
1
Collaboration
6
Computational
1
Conference
11
Day
1
Designation
1
Drug
5
Ema
2
Events
7
Expansion
3
Extension
2
Fda
3
Financial
6
Financial results
4
First
2
Health
2
Institute
2
License
3
Medical
3
Meeting
10
N/a
115
Nx-0479
2
Nx-1607
7
Nx-2127
13
Nx-5948
7
Offering
7
Pharmaceutical
2
Phase 1
3
Positive
3
Pre-clinical
6
Preclinical
7
Presentation
3
Program
2
Protein
11
Research
14
Results
13
Study
2
T-cell
3
Therapeutics
61
Therapy
2
Treatment
3
Trial
13
Update
7
Year
2
Entities
Abbott laboratories
1
Bio-path holdings, inc.
1
Eastgroup properties, inc.
1
Eli lilly and company
2
Enpro industries
2
Epizyme, inc.
1
Gilead sciences, inc.
4
Healthpeak properties, inc.
1
Igm biosciences, inc.
1
Incyte corporation
1
Iovance biotherapeutics, inc.
1
Johnson & johnson
1
Johnson controls international plc
1
Nurix therapeutics, inc.
147
Ocular therapeutix, inc.
1
Oric pharmaceuticals, inc.
1
Revolution medicines, inc.
1
Sanofi
18
Seagen inc.
3
Tg therapeutics, inc.
1
Toll brothers, inc.
1
Urban edge properties
1
Vertex pharmaceuticals incorporated
2
Xencor, inc.
1
Symbols
AAPL
1198
ABB
1433
ABBV
1030
ABLZF
1172
ABT
1796
ACN
602
AMGN
744
ARVL
4312
AVGO
597
AZN
668
BDX
796
BMY
662
BNPQF
1768
BNPQY
1768
CSCO
900
DHR
786
ERIC
1617
F
643
FNCTF
7224
FRBA
601
GE
919
GLAXF
661
GOOG
1297
GOOGL
1296
GSK
887
HON
1792
HUBS
1400
IBM
655
INTC
955
IT
595
JNJ
4602
LLY
1711
LTUM
973
LYV
717
MDT
1286
MMM
938
MS
4293
MSFT
1205
MT
592
NOK
916
NOKBF
992
NVO
636
NVS
1245
NVSEF
1035
ORCL
1161
PCRFF
651
PCRFY
651
PFE
693
PHG
963
PPRUF
1131
PPRUY
1132
SAP
1481
SAPGF
1235
SNOW
796
SNY
4558
SNYNF
3616
TEVJF
633
TMO
1630
VZ
1222
XYF
678
Exchanges
Nasdaq
147
Nyse
5
Crawled Date
2024 - 04 - 09
3
2024 - 04 - 03
2
2024 - 03 - 11
2
2023 - 12 - 11
4
2023 - 11 - 01
3
2023 - 10 - 25
2
2023 - 08 - 23
10
2023 - 03 - 20
2
2023 - 02 - 09
2
2022 - 07 - 08
1
2022 - 07 - 07
2
2022 - 06 - 30
1
2022 - 06 - 10
1
2022 - 06 - 03
1
2022 - 05 - 26
1
2022 - 04 - 07
1
2022 - 03 - 29
1
2022 - 03 - 09
1
2022 - 03 - 08
1
2022 - 02 - 11
1
2021 - 12 - 12
1
2021 - 11 - 15
5
2021 - 11 - 12
2
2021 - 10 - 27
1
2021 - 10 - 26
1
2021 - 10 - 22
1
2021 - 10 - 21
1
2021 - 10 - 14
1
2021 - 09 - 30
1
2021 - 07 - 13
1
2021 - 06 - 04
4
2021 - 06 - 01
1
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 21
2
2021 - 05 - 19
1
2021 - 05 - 18
2
2021 - 05 - 13
1
2021 - 05 - 12
1
2021 - 05 - 11
2
2021 - 04 - 29
2
2021 - 04 - 28
1
2021 - 04 - 20
2
2021 - 04 - 16
2
2021 - 04 - 13
1
2021 - 04 - 12
2
2021 - 04 - 09
1
2021 - 04 - 07
1
2021 - 04 - 02
4
2021 - 03 - 31
1
2021 - 03 - 25
1
2021 - 03 - 16
1
2021 - 03 - 10
1
2021 - 03 - 09
1
2021 - 03 - 05
1
2021 - 03 - 02
1
2021 - 02 - 16
1
2021 - 01 - 07
2
2021 - 01 - 05
1
2020 - 12 - 07
1
Crawled Time
00:00
3
02:00
1
04:00
1
11:00
8
12:00
6
12:01
1
12:03
1
12:15
1
12:20
3
12:30
1
13:00
8
13:20
5
13:30
1
14:00
2
15:00
1
15:04
1
15:30
1
16:00
1
16:20
1
17:00
18
18:00
5
19:00
6
20:00
14
21:00
33
21:03
1
22:00
15
23:00
8
Source
www.biospace.com
31
www.globenewswire.com
60
www.nurixtx.com
55
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NRIX
save search
Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published:
2024-04-16
(Crawled : 22:00)
- globenewswire.com
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
-3.55%
|
O:
3.07%
H:
0.79%
C:
-6.75%
offering
therapeutics
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
Published:
2024-04-12
(Crawled : 04:00)
- globenewswire.com
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
-15.24%
|
O:
-1.32%
H:
2.19%
C:
1.76%
million
offering
therapeutics
Nurix Therapeutics Announces Proposed Public Offering
Published:
2024-04-11
(Crawled : 20:00)
- globenewswire.com
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
-15.24%
|
O:
-1.32%
H:
2.19%
C:
1.76%
offering
therapeutics
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Published:
2024-04-10
(Crawled : 11:00)
- globenewswire.com
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
-0.01%
|
O:
-0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-0.99%
|
O:
-0.32%
H:
0.0%
C:
0.0%
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
0.32%
|
O:
18.35%
H:
1.98%
C:
-5.88%
first
update
therapeutics
financial
results
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Published:
2024-04-09
(Crawled : 20:00)
- globenewswire.com
LLY
|
News
|
$731.46
-1.91%
700K
|
Health Technology
|
-2.4%
|
O:
-0.71%
H:
0.0%
C:
0.0%
ORIC
|
$8.455
-3.59%
52K
|
Health Technology
|
-17.81%
|
O:
-2.81%
H:
1.54%
C:
-3.57%
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
0.32%
|
O:
18.35%
H:
1.98%
C:
-5.88%
therapeutics
Nurix Therapeutics Reports First Clinical Evidence of CNS Activity of NX-5948, a Brain-Penetrant, Orally Available, BTK Degrader in Development for B Cell Malignancies
Published:
2024-04-09
(Crawled : 17:00)
- globenewswire.com
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
1.58%
|
O:
1.26%
H:
0.0%
C:
0.0%
nx-5948
first
cell
for
therapeutics
Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
Published:
2024-04-09
(Crawled : 11:00)
- globenewswire.com
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
0.27%
|
O:
0.28%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-0.55%
|
O:
-0.38%
H:
0.95%
C:
0.83%
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
1.58%
|
O:
1.26%
H:
0.0%
C:
0.0%
protein
collaboration
extension
therapeutics
sanofi
Nurix Therapeutics to Participate in Upcoming Investor Conferences - April 03, 2024
Published:
2024-04-03
(Crawled : 12:00)
- biospace.com/
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
-4.91%
|
O:
-1.28%
H:
0.68%
C:
-0.55%
therapeutics
Nurix Therapeutics to Participate in Upcoming Investor Conferences
Published:
2024-04-03
(Crawled : 11:00)
- globenewswire.com
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
-4.91%
|
O:
-1.28%
H:
0.68%
C:
-0.55%
therapeutics
Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences
Published:
2024-04-02
(Crawled : 12:00)
- biospace.com/
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
-2.15%
|
O:
-1.59%
H:
6.37%
C:
4.57%
sciences
collaboration
extension
therapeutics
Nurix Therapeutics is Part of a Team of International Oncology Experts Selected as Cancer Grand Challenges Awardees to Address Pediatric Cancers Using Targeted Protein Degradation (TPD)
Published:
2024-03-25
(Crawled : 11:00)
- globenewswire.com
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
5.29%
|
O:
0.22%
H:
7.32%
C:
0.59%
cancer
international
protein
therapeutics
Nurix Presents the Discovery and Chemical Structure of First-in-Class CBL-B Inhibitor NX-1607 at the American Chemical Society (ACS) Meeting
Published:
2024-03-20
(Crawled : 13:30)
- globenewswire.com
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
10.91%
|
O:
-0.31%
H:
5.98%
C:
4.57%
nx-1607
meeting
Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 TrialNurix cleared to introduce new chirally controlled NX-2127 drug product and resume enrollment of new patients into the study
Published:
2024-03-11
(Crawled : 12:30)
- biospace.com/
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
-4.85%
|
O:
1.14%
H:
4.19%
C:
-5.93%
nx-2127
fda
cleared
drug
therapeutics
study
Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial
Published:
2024-03-11
(Crawled : 11:00)
- globenewswire.com
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
-4.85%
|
O:
1.14%
H:
4.19%
C:
-5.93%
nx-2127
fda
trial
therapeutics
Nurix Therapeutics to Participate in Upcoming Investor Conferences
Published:
2024-03-06
(Crawled : 21:00)
- globenewswire.com
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
-9.77%
|
O:
0.64%
H:
2.22%
C:
-7.99%
therapeutics
Nurix Therapeutics Announces Presentations at the American Association for Cancer Research (AACR) 2024 Annual Meeting
Published:
2024-03-05
(Crawled : 22:00)
- globenewswire.com
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
5.92%
|
O:
3.0%
H:
15.94%
C:
13.97%
association
cancer
research
meeting
therapeutics
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update
Published:
2024-02-15
(Crawled : 21:00)
- globenewswire.com
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
2.1%
|
O:
1.66%
H:
0.0%
C:
-1.59%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
1.18%
|
O:
-0.6%
H:
0.0%
C:
0.0%
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
43.45%
|
O:
-6.09%
H:
9.95%
C:
6.7%
year
update
therapeutics
financial
results
Nurix Therapeutics Announces Publication in the Journal Science Identifying a New Class of BTK Mutations That Are Susceptible to NX-2127, a Novel BTK and IKZF1/3 Degrader
Published:
2024-02-01
(Crawled : 21:00)
- globenewswire.com
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
73.37%
|
O:
-0.49%
H:
1.48%
C:
0.37%
nx-2127
publication
therapeutics
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory CLL and SLL
Published:
2024-01-16
(Crawled : 21:00)
- globenewswire.com
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
62.04%
|
O:
-3.21%
H:
3.32%
C:
-0.36%
nx-5948
fda
treatment
designation
therapeutics
Nurix Therapeutics Outlines 2024 Strategic Priorities with Advancement of Targeted Protein Modulation Pipeline in Cancer and Autoimmune Diseases
Published:
2024-01-08
(Crawled : 12:00)
- globenewswire.com
SNYNF
|
News
|
$94.25
480
|
Health Technology
|
-7.14%
|
O:
2.07%
H:
0.48%
C:
0.48%
SNY
|
News
|
$46.82
-1.82%
510K
|
Health Technology
|
-7.62%
|
O:
1.16%
H:
0.0%
C:
0.0%
NRIX
6 d
|
$13.66
-3.33%
130K
|
Health Technology
|
43.16%
|
O:
-1.01%
H:
2.76%
C:
1.94%
cancer
pipeline
protein
therapeutics
← Previous
1
2
3
4
5
6
7
8
Next →
Gainers vs Losers
58%
42%
Top 10 Gainers
CSSE
4
|
$0.3686
142.02%
76M
|
Consumer Services
CZOO
|
$11.685
134.17%
7.6M
|
BOF
|
$1.93
64.96%
55M
|
AMST
|
$3.14
57.0%
59M
|
Technology Services
LICN
|
$0.7885
40.8%
11M
|
TROO
|
$1.51
38.53%
5.6M
|
Manufacturing
MULN
|
News
|
$3.7
35.53%
6.4M
|
Information
WHLM
|
$6.61
30.12%
400K
|
Commercial Services
RILY
|
$27.91
28.5%
8.9M
|
Finance
RBBN
4
|
$3.25
26.46%
1.5M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.